AtriCure
ATRC
53.31
-0.37
-0.69%
AtriCure
US · ATRC
#2543 by market cap
Listed 1970
53.31
-0.37
-0.69%
Live - 5344 symbols - heartbeat 26s ago
· 2026-10-07 19:54
After-hours
53.31
0.00%
- Market cap
- 2.71B
- P/E (TTM)i
- 253.86
- P/Bi
- 5.25
- EPSi
- -0.24
- Div yieldi
- 0.00%
- 52W posi
- 77%
Reader sentiment
Are you bullish or bearish on ATRC?
Anonymous reader poll. Unscientific, not investment advice.
About AtriCure
AtriCure, Inc. engages in the development, manufacture, and sale of surgical ablation of cardiac tissue, and systems for the exclusion of the left atrial appendage. Its products include radio frequency (RF) ablation pacing and sensing, cryo, left atrial appendage management, soft tissue dissection, estech surgical instrumentation, and cart configuration. It operates through the following geographical segments: United States, Europe, Asia, and Other International. The company was founded in 1994 and is headquartered in Mason, OH.
- Founded
- 1994
- CEO
- Mr. David J. Drachman
- Employees
- 1,350
- Headquarters
- Mason, Ohio, United States of America
- Fiscal year end
- 12-31
- Website
- atricure.com
Company profile
- Exchange
- US
- Symbol
- ATRC
- Market-cap rank
- #2543
- Listing date
- 1970-01-01
- Market cap
- 2.71B
- Float cap
- 2.60B
- Shares out
- 50.87M
- Float shares
- 48.83M
Sectors & themes
Medical Instruments & Supplies
Fractional Shares JP
Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.